Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial

Mark R. Nelson; Galina Polekhina; Robyn L. Woods; Christopher M. Reid; Andrew M. Tonkin; Rory Wolfe; Anne M. Murray; Brenda Kirpach; Michael E. Ernst; Jessica E. Lockery; Raj C. Shah; Nigel Stocks; Suzanne G. Orchard; Zhen Zhou

doi:10.7326/M21-3823

Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial

Mark R. Nelson
, Galina Polekhina
, Robyn L. Woods
, Christopher M. Reid
, Andrew M. Tonkin
, Rory Wolfe
, Anne M. Murray
, Brenda Kirpach
, Michael E. Ernst
, Jessica E. Lockery
, Raj C. Shah
, Nigel Stocks
, Suzanne G. Orchard
, Zhen Zhou

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	761-764
Number of pages	4
Journal	Annals of Internal Medicine
Volume	175
Issue number	5
DOIs	https://doi.org/10.7326/M21-3823
Publication status	Published - 1 May 2022

Access to Document

10.7326/M21-3823

Cite this

Nelson, M. R., Polekhina, G., Woods, R. L., Reid, C. M., Tonkin, A. M., Wolfe, R., Murray, A. M., Kirpach, B., Ernst, M. E., Lockery, J. E., Shah, R. C., Stocks, N., Orchard, S. G., & Zhou, Z. (2022). Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial. Annals of Internal Medicine, 175(5), 761-764. https://doi.org/10.7326/M21-3823

@article{9887b7f407c54767a15caca41dcfd958,

title = "Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial",

author = "Nelson, \{Mark R.\} and Galina Polekhina and Woods, \{Robyn L.\} and Reid, \{Christopher M.\} and Tonkin, \{Andrew M.\} and Rory Wolfe and Murray, \{Anne M.\} and Brenda Kirpach and Ernst, \{Michael E.\} and Lockery, \{Jessica E.\} and Shah, \{Raj C.\} and Nigel Stocks and Orchard, \{Suzanne G.\} and Zhen Zhou",

year = "2022",

month = may,

day = "1",

doi = "10.7326/M21-3823",

language = "English",

volume = "175",

pages = "761--764",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "5",

}

Nelson, MR, Polekhina, G, Woods, RL , Reid, CM, Tonkin, AM, Wolfe, R, Murray, AM, Kirpach, B, Ernst, ME, Lockery, JE, Shah, RC, Stocks, N, Orchard, SG & Zhou, Z 2022, 'Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial', Annals of Internal Medicine, vol. 175, no. 5, pp. 761-764. https://doi.org/10.7326/M21-3823

TY - JOUR

T1 - Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years

T2 - A Subgroup Analysis of the ASPREE Randomized Trial

AU - Nelson, Mark R.

AU - Polekhina, Galina

AU - Woods, Robyn L.

AU - Reid, Christopher M.

AU - Tonkin, Andrew M.

AU - Wolfe, Rory

AU - Murray, Anne M.

AU - Kirpach, Brenda

AU - Ernst, Michael E.

AU - Lockery, Jessica E.

AU - Shah, Raj C.

AU - Stocks, Nigel

AU - Orchard, Suzanne G.

AU - Zhou, Zhen

PY - 2022/5/1

Y1 - 2022/5/1

UR - https://www.scopus.com/pages/publications/85130638816

U2 - 10.7326/M21-3823

DO - 10.7326/M21-3823

M3 - Letter

C2 - 35286146

AN - SCOPUS:85130638816

SN - 0003-4819

VL - 175

SP - 761

EP - 764

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 5

ER -

Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial

Access to Document

Other files and links

ASPREE Completion Project

A randomised double-blind placebo-controlled trial of aspirin in primary prevention of CVD events or dementia in the aged ID: 334047

Cite this

Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial

Access to Document

Other files and links

Projects

ASPREE Completion Project

A randomised double-blind placebo-controlled trial of aspirin in primary prevention of CVD events or dementia in the aged ID: 334047

Cite this